Church & Dwight Issues 2026 Guidance

Financial Performance - The company expects full-year 2026 reported EPS to increase approximately 18% to 22% and adjusted EPS to grow by 5% to 8% [1] - For the first quarter, the company anticipates organic sales growth of approximately 3% and a reported sales decline of about 1% due to exited businesses in 2025 [2] - In the fourth quarter, the company's net income was $143.5 million, or $0.60 per share, compared to $189.2 million, or $0.76 per share, last year; adjusted EPS was $0.86, up 11.7% [4] Sales and Growth Initiatives - The company expects volume-driven organic sales growth of approximately 3% to 4% in 2026, with reported sales declining by approximately 1.5% to 0.5% due to exited businesses [1] - The company announced three incremental growth initiatives: expansion of the ARM & HAMMER brand, growth of the Oral care portfolio with THERABREATH, and international expansion through acquisitions [3] - Organic sales growth for the fourth quarter was 0.7%, lower than the company's outlook of approximately 1.5%, but was 1.8% when excluding the exited VMS [4] Market Reaction - In pre-market trading on NYSE, Church & Dwight shares increased by 3.6% to $95.28 [5]